Business
Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS
Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS
About this update from Neuren Pharmaceuticals Limited
[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":256,"tagName":"div"}]